(Q36650851)

15 August 2017

Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation (English)

1 reference

15 August 2017

1 reference

Steve N Caritis

1

0 references

Donald Mattison

object named as

Donald Mattison

9

0 references

Anne Zajicek

object named as

Anne Zajicek

10

0 references

Gary D. V. Hankins

4

object named as

Gary D Hankins

1 reference

15 August 2017

5

Menachem Miodovnik

1 reference

15 August 2017

3

Raman Venkataramanan

1 reference

15 August 2017

2

Shringi Sharma

1 reference

15 August 2017

7

Jason G Umans

1 reference

15 August 2017

6

Mary F Hebert

1 reference

15 August 2017

Thomas Benedetti

8

1 reference

15 August 2017

Dawn Fischer

11

1 reference

15 August 2017

Aimee Jackson

12

1 reference

15 August 2017

Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetrical-Fetal Pharmacology Research Units Network

13

1 reference

15 August 2017

language of work or name

English

0 references

publication date

16 August 2012

1 reference

American Journal of Obstetrics and Gynecology

15 August 2017

1 reference

15 August 2017

207

1 reference

15 August 2017

5

1 reference

15 August 2017

398.e1-8

1 reference

Metabolism of 17-alpha-hydroxyprogesterone caproate by human placental mitochondria

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586341

Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586341

Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586341

Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586341

Simultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586341

Transplacental transfer and metabolism of 17-alpha-hydroxyprogesterone caproate

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586341

Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586341

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586341

Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586341

Teratogenicity of progestogens given during the first trimester of pregnancy

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586341

ACOG Committee Opinion number 419 October 2008 (replaces no. 291, November 2003). Use of progesterone to reduce preterm birth

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586341

Identification of enzymes involved in the metabolism of 17alpha-hydroxyprogesterone caproate: an effective agent for prevention of preterm birth

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586341

Evaluation of the use of prolution-depot (hydroxyprogesterone hexanoate) in early pregnancy

20 September 2018

1 reference

12 December 2020

Effects of prenatally administered 17 alpha-hydroxyprogesterone caproate on adolescent males

1 reference

12 December 2020

Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974

1 reference

12 December 2020

Intramuscular Administration of Hydroxyprogesterone Caproate in patients with Endometrial Carcinoma: Pharmacokinetics and effects on adrenal function

1 reference

12 December 2020

The risk of fetal anomalies as a result of progesterone therapy during pregnancy

1 reference

12 December 2020

A Trial of 17 Alpha-Hydroxyprogesterone Caproate to Prevent Prematurity in Twins

1 reference

12 December 2020

10.1016/J.AJOG.2012.08.015

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

22967833

1 reference